The University of Texas Medical Branch at Galveston was awarded a $535,896 delivery order against the National Institute of Allergy and Infectious Diseases Preclinical Models of Infectious Diseases 2017-2024 master IDIQ contract. The delivery order, issued by the National Institutes of Health National Institute of Allergy and Infectious Diseases, is for Task A-35 under the Preclinical Models of Infectious Diseases major program. Performance will take place in Galveston, Texas over a 18-month...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded the University of Texas Medical Branch at Galveston (UTMB) a $388,097 delivery order task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. This contract is for pre-clinical models of infectious diseases research. The award has no set-aside designation. As a prime contractor, UTMB...
The University of Texas Medical Branch at Galveston was awarded a $978,859 cost-no-fee delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Preclinical Models of Infectious Diseases multiple award indefinite-delivery/indefinite-quantity contract to issue a Program Component Management Identifier B13 task order. The work will be performed in Galveston, Texas from September 2021 through October...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $371,175 firm fixed price delivery order contract to the University of Texas Medical Branch at Galveston under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master indefinite delivery/indefinite quantity contract. The University of Texas Medical Branch at Galveston, operating under its parent company the University of Texas System, will provide preclinical models of infectious...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The order, valued at $1,727,489.49, is part of a larger indefinite delivery contract (IDC) between NIAID and UTMB to provide preclinical research services related to infectious diseases. The work will support NIAID's Pre-Clinical Models of Infectious Diseases program. This...
This is a $1,179,674.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB). The contract is for pre-clinical models of infectious diseases research and is part of NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract vehicle, which has a total ceiling value of $2,706,323.34. UTMB, a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $3,465,763 cost-reimbursement task order is part of a larger indefinite delivery contract (IDC) valued at $146.3 million that UTMB holds with NIAID to provide preclinical services for infectious disease research. Under this task order, UTMB will conduct studies...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to the University of Texas Medical Branch at Galveston (UTMB). The $393,542.08 delivery order falls under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract supports UTMB's provision of pre-clinical research services, such as testing...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $406,001.36 delivery order against its 2017-2024 Preclinical Models of Infectious Diseases master IDIQ to the University of Texas Medical Branch at Galveston. As the prime contractor, UTMB will utilize its expertise in preclinical infectious disease research to support NIAID's mission under the PCMID task order. Funded by the Department of Health and Human Services, the work will be performed in Galveston, Texas through June 2022. Pricing is set at cost with no fee for UTMB's efforts to advance the NIH's understanding and treatment of infectious diseases through preclinical testing and modeling.